詞庫查詢
查詢 Elsevier TF-IDF 關鍵詞（16,935 詞）與 THU 中文擴充詞庫。想知道自己的研究會命中哪些規則？先查這裡。
Elsevier TF-IDF 詞 16,935 筆
| SDG | 目標 | 詞 | 集合內文獻 | Scopus 文獻 | 佔比 | TF-IDF |
|---|---|---|---|---|---|---|
| 3 | 良好健康與福祉 | brca1 and brca2 mutation |
1,275 | 1,336 | 95% | 19.24 |
| 3 | 良好健康與福祉 | ovarian cancer (oc) |
2,648 | 2,898 | 91% | 19.24 |
| 3 | 良好健康與福祉 | pathways in cancer |
2,023 | 2,208 | 92% | 19.24 |
| 3 | 良好健康與福祉 | response evaluation criteria |
4,544 | 4,799 | 95% | 19.24 |
| 3 | 良好健康與福祉 | clinicopathologic parameters |
2,344 | 2,567 | 91% | 19.24 |
| 3 | 良好健康與福祉 | breast cancer gene |
3,096 | 3,372 | 92% | 19.24 |
| 3 | 良好健康與福祉 | people with cancer |
1,843 | 2,003 | 92% | 19.24 |
| 3 | 良好健康與福祉 | type 1 dm |
1,420 | 1,509 | 94% | 19.24 |
| 3 | 良好健康與福祉 | glucagon-like peptide-1 receptor agonists |
1,435 | 1,527 | 94% | 19.24 |
| 3 | 良好健康與福祉 | anti-tb drug |
2,282 | 2,499 | 91% | 19.24 |
| 3 | 良好健康與福祉 | her2-overexpressing |
1,202 | 1,249 | 96% | 19.24 |
| 3 | 良好健康與福祉 | entecavir |
2,965 | 3,236 | 92% | 19.24 |
| 3 | 良好健康與福祉 | oncogenic driver |
2,327 | 2,549 | 91% | 19.24 |
| 3 | 良好健康與福祉 | hormone-refractory prostate cancer |
1,277 | 1,339 | 95% | 19.24 |
| 3 | 良好健康與福祉 | molecular targeted therapy |
2,355 | 2,580 | 91% | 19.24 |
| 3 | 良好健康與福祉 | aggressive cancer |
3,635 | 3,922 | 93% | 19.24 |
| 3 | 良好健康與福祉 | progression of ckd |
1,723 | 1,865 | 92% | 19.24 |
| 3 | 良好健康與福祉 | exposure to air pollution |
2,630 | 2,880 | 91% | 19.24 |
| 3 | 良好健康與福祉 | lenvatinib |
1,710 | 1,850 | 92% | 19.24 |
| 3 | 良好健康與福祉 | arsenic exposure |
3,410 | 3,696 | 92% | 19.24 |
| 3 | 良好健康與福祉 | micrometastasis |
2,679 | 2,933 | 91% | 19.24 |
| 3 | 良好健康與福祉 | cervical cancer cell line |
2,421 | 2,653 | 91% | 19.24 |
| 3 | 良好健康與福祉 | cancer cell invasion |
3,471 | 3,758 | 92% | 19.24 |
| 3 | 良好健康與福祉 | egfr-mutated |
1,316 | 1,386 | 95% | 19.24 |
| 3 | 良好健康與福祉 | rectal cancer treatment |
1,448 | 1,543 | 94% | 19.24 |
| 3 | 良好健康與福祉 | cancer network |
5,074 | 5,290 | 96% | 19.24 |
| 3 | 良好健康與福祉 | baseline cd4 |
2,080 | 2,274 | 91% | 19.24 |
| 3 | 良好健康與福祉 | multidrug-resistant tuberculosis |
3,496 | 3,784 | 92% | 19.24 |
| 3 | 良好健康與福祉 | chronic hepatitis c infection |
1,518 | 1,626 | 93% | 19.24 |
| 3 | 良好健康與福祉 | advanced pancreatic cancer |
3,287 | 3,572 | 92% | 19.24 |
| 3 | 良好健康與福祉 | hereditary nonpolyposis colorectal cancer |
1,680 | 1,816 | 93% | 19.24 |
| 3 | 良好健康與福祉 | direct-acting antiviral agents |
1,232 | 1,286 | 96% | 19.24 |
| 3 | 良好健康與福祉 | esophageal cancer cell |
1,791 | 1,945 | 92% | 19.24 |
| 3 | 良好健康與福祉 | axillary lymph node dissection (alnd) |
1,354 | 1,432 | 95% | 19.24 |
| 3 | 良好健康與福祉 | asthma quality of life |
1,201 | 1,249 | 96% | 19.24 |
| 3 | 良好健康與福祉 | raf inhibitor |
2,969 | 3,243 | 92% | 19.24 |
| 3 | 良好健康與福祉 | low rectal cancer |
1,783 | 1,936 | 92% | 19.24 |
| 3 | 良好健康與福祉 | pulmonary tuberculosis (ptb) |
1,689 | 1,827 | 92% | 19.24 |
| 3 | 良好健康與福祉 | diffuse large b-cell lymphomas |
1,290 | 1,356 | 95% | 19.24 |
| 3 | 良好健康與福祉 | breast cancer recurrence |
2,036 | 2,226 | 91% | 19.24 |
| 3 | 良好健康與福祉 | hiv drug resistance |
1,468 | 1,568 | 94% | 19.24 |
| 3 | 良好健康與福祉 | asthma medication |
2,570 | 2,818 | 91% | 19.24 |
| 3 | 良好健康與福祉 | human hepatocellular carcinoma cells |
1,457 | 1,555 | 94% | 19.24 |
| 3 | 良好健康與福祉 | anti-cancer treatment |
1,997 | 2,182 | 92% | 19.23 |
| 3 | 良好健康與福祉 | brca2 gene |
2,049 | 2,241 | 91% | 19.23 |
| 3 | 良好健康與福祉 | ductal carcinoma in situ (dcis) |
4,081 | 4,365 | 93% | 19.23 |
| 3 | 良好健康與福祉 | malignant cancer |
2,791 | 3,056 | 91% | 19.23 |
| 3 | 良好健康與福祉 | coronary artery calcium |
3,358 | 3,647 | 92% | 19.23 |
| 3 | 良好健康與福祉 | adjuvant chemoradiotherapy |
4,370 | 4,642 | 94% | 19.23 |
| 3 | 良好健康與福祉 | cancer population |
3,202 | 3,487 | 92% | 19.23 |